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Summary
Streptococcal pyrogenic exotoxin (Spe) A expression is epidemiologically 
linked to streptococcal tonsillo-pharyngitis and outbreaks of scarlet fever, 
although the mechanisms by which superantigens confer advantage to Strep-
tococcus pyogenes are unclear. S. pyogenes is an exclusively human pathogen. 
As the leucocyte profile of tonsil is unique, the impact of SpeA production 
on human tonsil cell function was investigated. Human tonsil cells from 
routine tonsillectomy were co-incubated with purified streptococcal supe-
rantigens or culture supernatants from isogenic streptococcal isolates, dif-
fering only in superantigen production. Tonsil cell proliferation was quanti-
fied by tritiated thymidine incorporation, and cell surface characteristics 
assessed by flow cytometry. Soluble mediators including immunoglobulin 
were measured using enzyme-linked immunosorbent assay. Tonsil T cells 
proliferated in response to SpeA and demonstrated typical release of pro-
inflammatory cytokines. When cultured in the absence of superantigen, 
tonsil preparations released large quantities of immunoglobulin over 7 days. 
In contrast, marked B cell apoptosis and abrogation of total immunoglobulin 
(Ig)A, IgM, and IgG production occurred in the presence of SpeA and 
other superantigens. In SpeA-stimulated cultures, T follicular helper (Tfh) 
cells showed a reduction in C-X-C chemokine receptor (CXCR)5 (CD185) 
expression, but up-regulation of OX40 (CD134) and inducible T cell co-
stimulator (ICOS) (CD278) expression. The phenotypical change in the Tfh 
population was associated with impaired chemotactic response to CXCL13. 
SpeA and other superantigens cause dysregulated tonsil immune function, 
driving T cells from Tfh to a proliferating phenotype, with resultant loss 
of B cells and immunoglobulin production, providing superantigen-pro-
ducing bacteria with a probable survival advantage.
Keywords: antibody, group A streptococcus, SpeA, streptococcal pyrogenic 
exotoxin A, streptococcus pyogenes
Introduction
The human pathogen Streptococcus pyogenes can produce 
up to 11 different secreted superantigens that contribute 
to the features of cytokine-induced toxic shock during 
lethal, invasive infections such as necrotizing fasciitis [1]. 
Invasive infections are, however, rare compared with 
symptomatic non-invasive disease that occurs in the naso-
pharynx, manifest as pharyngitis, tonsillitis and the 
childhood exanthem scarlet fever. Indeed, in human popu-
lations, the throat and tonsils represent the main reservoir 
of S. pyogenes carriage.
When secreted in the vicinity of host leucocytes, strep-
tococcal superantigens bind host major histocompatibility 
complex II (MHC-II) outside the antigen groove and ligate 
a variably discrete repertoire of T cell receptor variable 
β chain (TCR-Vβ) subunits, thereby leading to mass acti-
vation and proliferation of all target populations of T 
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cells that bear relevant TCR-Vβ [2]. As such, the evolu-
tionary benefit of superantigen production is most probably 
conferred to S. pyogenes through activation of T cells 
within the nasopharynx and, in particular, the human 
tonsil, in ways that provide a survival or transmission 
advantage.
The tonsil is a solid secondary lymphoid organ that 
possesses only efferent lymphatic drainage; the leucocyte 
populations that constitute the tonsil are distinct from those 
present in peripheral blood and also distinct from mucosal 
lymphoid tissue. The tonsil comprises follicular dendritic 
cells, T follicular helper (Tfh) cells and B cells arranged 
in germinal centres, bounded by the specialized tonsil 
mucosal epithelium in the posterior nasopharynx [3].
Streptococcal expression of superantigen genes is 
increased upon exposure to tonsil epithelium [4] and 
models of tonsillo-pharyngitis [5]. Furthermore, the phage-
encoded superantigen streptococcal pyrogenic exotoxin A 
(SpeA) is required for successful nasopharyngeal infection 
with S. pyogenes in human leucocyte antigen (HLA)-DQ8 
superantigen-sensitive transgenic mice, albeit that mice 
lack tonsils [6]. It is therefore remarkable that, in contrast 
to work that has elucidated effects of superantigens on 
rodent spleen cells and leucocytes of human peripheral 
blood [1], the impact of superantigens on human tonsil 
has not been addressed. Using the phage-encoded toxin 
SpeA, which has been implicated in the emergence of 
severe S. pyogenes infections in recent decades, as a para-
digm of a streptococcal superantigen [7] we set out to 
conduct a systematic examination of responses to supe-
rantigen using both human tonsil histocultures and cultured 
cell suspensions.
Materials and methods
Reagents
Recombinant toxins were purchased from Toxin 
Technology (Sarasota, FL, USA). Recombinant strepto-
coccal mitogenic exotoxin Z (SmeZ) and Streptococcal 
pyrogenic exotoxin J (SpeJ) were a kind gift of Thomas 
Proft (Auckland, NZ), [8]. Concanavalin A (Sigma, 
Welwyn Garden City, UK), anti-CD3 and anti-CD28 
(Miltenyi Biotech, Woking, UK) were used at 1  μg/ml, 
as per the supplier’s recommendations. Anti-cytokine 
antibodies were purchased from R&D Systems 
(Abingdon, UK). Antibodies for flow cytometry were 
purchased from BD Biosciences (Swindon, UK), con-
jugated to either fluorescein isothiocyanate (FITC), phy-
coerythrin (PE), PE cyanin 5 (PECy5) or peridinin 
chlorophyll (PerCP)Cy7, with the following exceptions: 
TCR-Vβ antibodies, isotype controls and TCR-Vβ rep-
ertoire kit (IOTest Beta Mark) from Beckman Coulter 
(Marseilles, France), CXCR5 PE and isotype control 
from R&D Systems, CXCR5 PE-Cy5 and isotype control 
from eBioscience (High Wycombe, UK).
Bacterial strains
Isogenic emm 1/M1 S. pyogenes isolates that differ in 
SpeA production [9] or isogenic emm 89/M89 isolates 
that differ in SmeZ production [10] were cultured over-
night in RPMI supplemented with 10% fetal bovine 
serum (FBS) and cell-free supernatants prepared as 
previously reported [11].
Human tonsil donors and ethics
Fresh tonsils were obtained by the Imperial College 
Healthcare NHS Trust Tissue Bank (ICHTB) from 
anonymized adult donors (aged >  16  years) undergoing 
routine tonsillectomy and consenting to the use of tissue 
surplus to diagnostic requirement for research. The use 
of donor tissue was approved by a Research Ethics 
Committee (07/Q0407/38) and by the Tissue Management 
Committee of the ICHTB (R12011). Donors (53 females; 
12 males) had a median age of 28  years (range  =  17–59). 
Indication for tonsillectomy was prolonged or recurrent 
tonsillitis in all cases, with the exception of four males 
with sleep apnoea. Other medical and demographic data 
were not available.
Tonsil cell suspensions and histocultures
Tonsil cell suspensions and histocultures were prepared 
according to previously published methods [12] with 
modification to include kanamycin 100 µg/ml and ampho-
tericin 2·5  µg/ml. Cells were co-incubated with different 
concentrations of purified superantigen or filter-sterilized 
bacterial supernatant. At the end of experiments, tonsil 
cells were harvested into sterile tubes, centrifuged at 300 g 
for 10  min, and tonsil supernatant collected and stored 
at –20°C. Tonsil cells were either used immediately or 
stored at –80°C in Freezimix (90% fetal calf serum; 
Invitrogen, Basingstoke, UK) and 10% dimethylsulphoxide 
(DMSO); Sigma) for later flow cytometry analysis. For 
histocultures, the capsule, connective tissue and any dam-
aged tissue was removed from tonsil and remaining tissue 
dissected into 2–3-mm blocks then placed on 
1  ×  1  ×  2  cm Gelfoam constructs (Upjohn, Pfizer, 
Maidenhead, UK). Histoculture supernatants were collected 
from the Gelfoam constructs at the end of the experiment 
and stored at –20°C.
Cellular and immunological assays
Soluble mediators in cell-free tonsil supernatants were 
measured by enzyme-linked immunosorbent assay (ELISA) 
[immunoglobulin enzyme immunoassay (EIA); Bethyl Labs, 
Montgomery, TX, USA; cytokine Duosets EIA kits, R&D 
Systems, Abingdon, UK]. Tonsil cell proliferation was 
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measured by [3H]-labelled tritium incorporation and 
TCR-Vβ subsets were evaluated by flow cytometry. Human 
tonsil cells were separated using AutoMACS Bead 
Technology (Miltenyi Biotech), either before or after cul-
ture. T cells were isolated using CD2-positive selection. 
B cells were then isolated using the B cell-negative selec-
tion kit, which positively selected for CD2, CD14, CD16, 
CD36, CD43 and CD235a, leaving only B cells remaining. 
Confirmation of the quality of separation was performed 
using surface staining for CD3 (T cells) and CD20 (B 
cells), and gave > 99% cell purity on each occasion. Tonsil 
cell migration in response to CXCL13 was evaluated using 
the Transwell technique, as previously described [13], using 
tonsil cells preincubated with SpeA 1000 ng/ml or medium 
only for 6  days, and 100  nM of CXCL13, a concentration 
approximately five times that secreted by unstimulated 
tonsil cell cultures. After 1 h, cell suspensions in the lower 
chamber were aspirated and stained using CD4-FITC or 
CD4-PE/Cy5 and CXCR5-PE. Migrated CD4+CXCR5+ cells 
were enumerated using Countbright beads (Invitrogen) 
and known percentage positivity in each sample in trip-
licate. Chemotactic index was calculated by dividing the 
mean number of cells migrating towards CXCL13 by the 
number of cells migrating towards a buffer control.
Statistics
All statistical analyses, unless stated specifically elsewhere, 
were performed using Graphpad Prism version 5 software. 
All data were non-parametric; two group comparison 
Mann–Whitney tests were performed, or Wilcoxon’s 
signed-ranked test for paired data and two-way analysis 
of variance (anova) for multiple grouped data (migration 
assay and bacterial supernatant IgG). For comparison of 
multiple groups, a one-way anova (Kruskal–Wallis, or 
Friedman for paired data) test was performed. Statistical 
tests were not performed on groups with a sample size 
smaller than three. A probability value <  5% was classed 
as significant (P   <  0·05).
Results
Tonsil T cells proliferate in response to superantigens 
and release proinflammatory cytokines
To establish that fresh human tonsil cell suspensions were 
responsive to streptococcal superantigens, cells were 
exposed to purified superantigens SpeA and SmeZ), and 
proliferation assessed by tritiated thymidine incorporation. 
Human tonsil cells demonstrated dose-responsive prolif-
eration similar to that seen with peripheral blood mono-
nuclear cells (Fig. 1a). Specific superantigen responses 
were also seen using cell-free bacterial culture supernatants 
from isogenic emm 1 and emm 89 streptococcal strains 
differing only in SpeA or SmeZ expression, respectively 
(Fig. 1b). Characteristic expansion of TCR-Vβ T cell sub-
sets was demonstrated in tonsil cells, most clearly in 
response to SmeZ (Supporting information, Fig. 1), due 
to the high proportion of TCR-Vβ8 cells present in 
unstimulated tonsil preparations.
Tonsil cells stimulated with SpeA produced a range of 
proinflammatory cytokines over 7  days compared to 
unstimulated controls, where there was minimal cytokine 
production (Fig. 2 and Table 1). Production of interleukin 
(IL)-2 by stimulated tonsil cells was rapid and preceded 
production of tumour necrosis factor (TNF)-β 
(lymphotoxin-α), which was followed by production of 
IL-17 and interferon (IFN)-γ. Taken together, the findings 
confirmed that explanted tonsil cell suspensions responded 
to streptococcal superantigens in a manner similar to 
previously demonstrated responses in peripheral blood.
Superantigen stimulation causes a loss of tonsil B cells 
and reduction in immunoglobulin production
Unstimulated tonsil cell suspensions comprise a mix of 
predominantly B and T cells, representative of the germinal 
centres present within tonsils. Despite expansion of the 
T cell population in tonsil cell suspensions over a 5-day 
period (Fig. 3a,b), stimulation with SpeA caused a pro-
found loss of B cells during the same time-period, com-
pared with unstimulated cells (Fig. 3a and 3c). B cells 
demonstrated apoptosis, as shown by increased expression 
of annexin V and propidium iodide (PI), with the change 
evident after 4–5 days of co-culture with SpeA, in contrast 
to the expanded T cell population (Fig. 3d–i).
B cells in unstimulated tonsil cell culture began pro-
ducing increased quantities of immunoglobulin (IgG, A 
and M) from day  4 of cell culture (Fig. 4). However, in 
SpeA-stimulated cultures this response was abrogated, with 
no increase from baseline (Fig. 4a–d). To ensure that the 
processing of tonsil into single-celled suspensions did not 
affect immunoglobulin release, tonsils were instead cultured 
as histocultures, either unstimulated or treated with SpeA. 
Histocultures have a shorter survival time in vitro , hence 
responses were measured after 48 h incubation with SpeA, 
before onset of tissue necrosis. Tonsil histocultures at 
48 h produced concentrations of IgG that were two orders 
of magnitude greater than tonsil cell suspensions. Similar 
to results using cell suspensions, a reduction in total IgG 
was again demonstrated in SpeA-stimulated histocultures 
(Fig. 4e).
To determine if this effect was specific to SpeA, or might 
result from any mitogen-driven tonsil T cell 
proliferation, tonsil cell suspensions were stimulated with 
a range of known superantigens and mitogens (Fig. 5). A 
reduction in total immunoglobulin was again demonstrated 
following co-incubation with other streptococcal 
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superantigens (SpeJ and SmeZ) and staphylococcal supe-
rantigens [staphylococcal enterotoxins (SE) B, SEC and 
toxic shock syndrome toxin-1 (TSST-1)] in a dose-depend-
ent manner (Fig. 5a–f). The effect was also demonstrated 
with the lectin mitogen concanavalin A (Fig. 5g). Stimulation 
with CD28 antibody produced an increase in immuno-
globulin production by tonsil cell suspensions, while no 
change was induced by anti-CD3. However, combined 
anti-CD3 and anti-CD28 resulted in a decrease in IgG 
production by tonsil cells (Fig. 5h). Bacteria produce a 
complex mix of factors that together might be expected 
to increase IgG production by tonsil B cells, notwithstand-
ing any effect of superantigens. However, exposure of tonsil 
cells to 1% S. pyogenes culture supernatant led to a 
reduction in tonsil IgG which, using supernatants from 
isogenic strains differing only in SpeA production, could 
be specifically ascribed to production of SpeA (Fig. 5i). 
Transferred cytokine-rich supernatants from SpeA-
stimulated tonsil cell suspensions did not elicit inhibition 
of total immunoglobulin release when added to unstimulated 
tonsil cells, and the effect was not reversed by antibodies 
neutralizing individual cytokines (Supporting information, 
Fig. 2). The data showed that superantigen-induced T cell 
proliferation and activation in the tonsil results in B cell 
apoptosis and loss of function, manifest as immunoglobulin 
suppression; this effect was observed in tonsil cell suspen-
sions and histocultures and did not appear to be the direct 
result of any transferrable soluble mediator.
Fig. 1. Tonsil cell proliferation in response to purified streptococcal superantigens or streptococcal supernatants. Tonsil cells were stimulated for 
7 days with different concentrations of purified superantigens streptococcal pyrogenic exotoxin (SpeA) or streptococcal mitogenic exotoxin Z (SmeZ) 
(a) or 1% supernatants from isogenic emm 1 or emm 89 strains (b). emm 1 supernatants were from parent [wild-type (WT)]; isogenic speA negative 
(WTΔspeA); and complemented (WTΔspeAcomp) strains. emm 89 supernatants were from parent (WT); isogenic smeZ -negative (WTΔsmeZ); 
complemented (WTΔsmeZcomp); and SpeA-complemented (WTspeAcomp) strains. Unstimulated control cells (neg) were incubated with medium 
alone. Data show one donor with mean and experimental triplicates; representative of six different tonsil donors for supernatants (P  = 0·0047, 
Friedman test).
Streptococcal superantigens cause B cell death and immunoglobulin loss
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Phenotypical change in Tfh cells following SpeA 
stimulation
Tfh cells represent a major proportion of T cells in tonsil 
suspensions and are necessary for B cell maturation and 
function in germinal centres. SpeA induced a significant 
expansion and increase in expression of key Tfh activa-
tion markers OX40 (CD134) and inducible T cell co-
stimulator (ICOS) (CD278) (Fig. 6a–d). Although the 
population of CXCR5 (CD185)-expressing T cells expanded 
in response to SpeA, expression of CXCR5 (CD185) 
reduced over time, despite increase in other activation 
markers (Fig. 6e,f). To determine if the observed 
reduction in CXCR5 (CD185) expression was likely to 
be functionally relevant, CXCL13 (B cell-attracting 
chemokine 1) production and CXCL13 chemotaxis assays 
were undertaken: Despite increased tonsil cell production 
of CXCL13 in response to SpeA, SpeA-stimulated tonsil 
T cells demonstrated reduced chemotactic responses 
towards CXCL13 compared with controls (Fig. 6g,h).
Discussion
Primary human tonsil cells demonstrate TCR-Vβ-specific 
clonal T cell expansion and proinflammatory cytokine 
release in response to streptococcal superantigens. Based 
Fig. 2. Streptococcal pyrogenic exotoxin (SpeA) induces proinflammatory cytokine release by stimulated tonsil T cells. Tonsil cells were stimulated 
for 1 week with recombinant SpeA 100 ng/ml (blue) or unstimulated control (black) and supernatants harvested daily from days 1 to 8 of culture. 
Harvested supernatants were then analysed by enzyme-linked immunosorbent assay (ELISA) for the presence of cytokines tumour necrosis factor 
(TNF)-α (a), TNF-β (b), interleukin (IL)-17 (c), IL-2 (d), IL-10 (e) and interferon (IFN)-γ (f). Mean and standard deviation of experimental 
triplicates for a single representative donor is shown for each cytokine, representative of between five and 12 different donors measured for each 
cytokine (Table 1).
Table 1. Peak cytokine production in unstimulated and SpeA-stimulated tonsil cells
Cytokine
Peak day of 
production
Median unstimulated 
(pg/ml)
Median SpeA-stimulated 
(pg/ml)
Number of tonsil 
donors Significance§
IL-2 2 30 938 5 P  = 0·012
IL-10 4 86 581 5 P  = 0·036
IL-17 4-7 567 2241 7 P  = 0·0156
TNF-α 4 145 1054 12 P  = 0·0005
TNF-β 4 143 3616 8 P  = 0·0078
IFN-γ 5 10 535 7 P  = 0·0156
TGF-β 7 129 480 7 P  = 0·0156
§Interleukin (IL)-2 and IL-10 were assessed by Mann–Whitney U -test, as numbers were too small for effective pairing; others were assessed using the 
Wilcoxon matched-pairs signed-rank test. SpeA = streptococcal pyrogenic exotoxin; TNF = tumour necrosis factor; IFN = interferon; TGF = trans-
forming growth factor.
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in a non-sterile site, the tonsil is repeatedly exposed to 
bacterial and other antigens; as such, B cells that reside 
in germinal centres are primed to release significant amounts 
of immunoglobulin even at rest, supported by a large 
population of CXCR5-expressing Tfh cells that are resident 
in the tonsil [14]. Focusing on the phage-encoded supe-
rantigen SpeA, implicated in the success of the globally 
successful emm /M1 S. pyogenes lineage [7,15], we identified 
a paradoxical reduction in release of multiple classes of 
immunoglobulin including IgG, IgA and IgM in response 
to superantigen. This occurred despite the marked increase 
in proinflammatory cytokine secretion by tonsil cells. 
Diminution of tonsil immunoglobulin production was 
reproduced by all superantigens tested, suggesting a com-
mon mechanism of immune subversion for both S. pyogenes 
and Staphylococcus aureus , and was recapitulated by anti-
CD28/anti-CD3. In the more physiological context of 
bacterial supernatant, that contains mixtures of otherwise 
potent superantigens, it was possible to assign a more 
specific role to SpeA, suggesting that SpeA may play a 
pivotal role in diminution of antibody production either 
alone or in synergy with other superantigens.
The participating constituent cells in tonsils are mark-
edly different to those in peripheral blood, and cell 
Fig. 3. Streptococcal pyrogenic exotoxin (SpeA) results in expansion of tonsil T cells but apoptosis of B cells. Tonsil cells were analysed over 5 days’ 
incubation with SpeA 100 ng/ml. Compared to unstimulated controls, SpeA resulted in increased total T cell count but a decrease in the total B cell 
count (a) (n  = 8 tonsil donors, P  = 0·0039*** for T cells, P  = 0·0078*** for B cells, both Wilcoxon’s paired signed-rank t -test). The proportions of 
CD3+CD4+ tonsil cells (b) increased in the presence of SpeA by day 3, while the reduction in B cells expressing CD20 (c) became apparent by day 4 
(single donor time–course shown, representative of five donors). Annexin V and propidium iodide (PI) staining of the whole cell population showed 
an overall reduction in apoptosis in SpeA-stimulated cells (28·8%) compared to unstimulated cells (42·1%) (d,g). After cell separation (autoMACS), T 
cells showed reduced apoptosis in the presence of SpeA (27·8 versus 42·8%) (e,h), while B cells showed a marked increase in apoptosis (58·3 versus 
23·7%) (f,i), representative plot; two different tonsil donors.
Streptococcal superantigens cause B cell death and immunoglobulin loss
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populations are in close contact. Tonsil T cell populations 
expanded by SpeA demonstrated an altered phenotype, 
expressing high levels of the TNF receptor superfamily 
members OX40 (CD134) and ICOS (CD278), but para-
doxically low levels of CXCR5 (CD185) compared with 
unstimulated controls, with reduced chemotactic responses 
to the chemokine CXCL13. Taken together, the data point 
to a specific role for streptococcal superantigens in recruit-
ing and diverting tonsil follicular T helper cells from 
their primary purpose, thereby undermining antibody 
response during S. pyogenes infection, and conceivably 
other infections that rely on antibody production in the 
tonsil. Indeed, a recent report suggested that the presence 
of superantigen-associated Staph. aureus in tonsil may 
result in skewing of the tonsil TCR-Vβ repertoire [16]. 
Expansion of T cells in tonsil cultures was accompanied 
by a paradoxical absolute reduction in B cells that was 
associated with evidence of B cell apoptosis.
SpeA was first reported to reduce immunoglobulin 
production almost 50  years ago; a reduction in immu-
noglobulin-secreting B cells was accompanied by a para-
doxical increase in spleen weight and 100% expansion in 
total number of cells in rabbits exposed to SpeA [17]. 
Notwithstanding the recognized poor sensitivity of murine 
cells to superantigens, both SpeA and SpeC were shown 
in older reports to suppress murine spleen B cell IgM 
responses in a manner that required altered activity of 
T cells, raising the possibility of either reduced T helper 
cell function or an increase in T suppressor activity [18]. 
While superantigen-induced T cell-derived secreted prod-
ucts were reported by some to suppress immunoglobulin-
secreting cells [1,19,20], others have reported 
contact-dependent T cell-induced Fas (CD95)-dependent 
B cell apoptosis following superantigen exposure in human 
peripheral blood mononuclear cells, although in our study 
we did not investigate Fas (CD95)–Fas ligand (CD95L) 
interactions. In the tonsil cultures used in the current 
report, reduction in immunoglobulin required co-incu-
bation of B and T cells and could not be recapitulated 
by secreted products from T cells, albeit that tonsil cells 
were exposed to only a 1% SpeA-exposed tonsil cell 
medium. This points to a requirement for contact between 
the effector T cells and apoptosing B cells, at least in 
the experimental setting, but does not exclude a role for 
broad disruption of TfH-B cross-talk by the cytokine 
cocktail elicited by superantigen exposure.
Within the tonsil and other solid lymphoid organs, dis-
tinct populations of Tfh cells, characterized by expression 
of CXCR5 (CD185), OX40 (CD134) and PD1 (CD279), 
are now recognized to underpin B cell viability through 
Fig. 4. Reduction in tonsil cell immunoglobulin release in response to streptococcal pyrogenic exotoxin (SpeA). Tonsil cells were stimulated for 
1 week with recombinant SpeA 100 ng/ml (blue) or unstimulated control (black) and supernatants harvested daily from days 1 to 8 of culture (a). 
Harvested supernatants were then analysed by enzyme-linked immunosorbent assay (ELISA) for the presence of total immunoglobulin (Ig)G. Means 
and standard deviation (s.d.) of experimental triplicates from a single donor are shown at each time-point, representative of five different donors. 
SpeA significantly reduced tonsil cell production of immunoglobulin (Ig)G (b, n  = 16 donors, P  = 0·0005***); IgA (c, n  = 8 donors, P  = 0·0078**); and 
IgM (d, n  = 7 donors, P  = 0·0156*) in comparison to unstimulated cultures, when a wider pool of donors was tested after 7 days of co-incubation with 
SpeA. Horizontal bars represent median values. Non-SpeA-exposed control tonsil histocultures from seven donors produced large quantities of IgG 
(ng/ml), and this was diminished by co-culture with SpeA (e) P  = 0·014* (all Wilcoxon’s paired signed-rank t -test).
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migration to germinal centres in response to CXCL13, a 
chemokine also required for B cell migration to form fol-
licles [14]. More recently, regulatory T follicular cells have 
been described to repress B cell activity, and the net bal-
ance between the two T cell populations is believed to 
underlie B cell activity in lymphoid tissue [21]. In the 
static model used in our study, however, forkhead box P3 
(FoxP3) was detected in approximately 5% of T cells, and 
we therefore conclude that, in the ex-vivo setting described 
in the current work, classically defined regulatory cells are 
unlikely to have played a major role. This does not exclude 
the possibility that superantigen-stimulated regulatory fol-
licular T cells may play a greater role in vivo in lymph 
nodes draining sites of infection, noting that superantigens 
are reported to activate regulatory T cells in peripheral 
blood [22]. In this study, the phenotype of T cells in SpeA-
expanded tonsil cell cultures was significantly and 
consistently altered such that expression of CXCR5 (CD185) 
reduced, potentially impacting on chemotactic function, 
while other markers of Tfh activation such as ICOS (CD278) 
were increased. We speculate that within the tonsil, reduced 
chemotactic function may render the Tfh cells unable to 
migrate to germinal centres and promote B cell antibody 
production, providing one potential explanation for our 
findings in histocultures, although we did not specifically 
examine the chemotactic function of an isolated TfH popu-
lation. It is also possible that the augmented production 
of CXCL13 by tonsil cells in response to SpeA in some 
way corrupts the normal homeostasis of B or T cell migra-
tion. Notwithstanding these findings, it is clear that the 
altered phenotype of this T cell population in the presence 
of superantigens requires further evaluation.
Study of human tonsil cellular responses are necessarily 
limited by availability of surgical tissue, donor heterogeneity, 
Fig. 5. Immunoglobulin (Ig)G production by tonsil cell suspensions is reduced by superantigens and T cell mitogens. IgG release in the presence of 
different concentrations of bacterial superantigens was tested at 1 week: streptococcal pyrogenic exotoxin (SpeA) (a), staphylococcal enterotoxin B 
(SEB) (b), staphylococcal enterotoxin C (SEC) (c), streptococcal pyrogenic exotoxin J (SpeJ) (d), streptococcal mitogenic exotoxin Z (SmeZ) and 
toxic shock syndrome toxin 1 (TSST-1) (f). For comparison, the T cell mitogen concanavalin (Con) A was tested (g) and T cell stimulation using 
anti(α-)CD3 and CD28 antibodies (h). Mean and standard deviation (s.d.) of experimental triplicates from one representative tonsil donor (data 
representative of experiments using three donors for the different superantigens, two for concanavalin A and α-CD3/28. IgG release was measured 
from cells cultured in the presence of emm1 S. pyogenes culture supernatants differing only in SpeA production (i). Supernatants containing SpeA 
[wild-type (WT) and SpeA-complemented, ΔspeAcomp] reduced IgG production, in contrast to supernatant from a SpeA gene deletion mutant 
(ΔspeA). Mean and standard deviation (s.d.) of five donor tonsils shown, P  < 0·0001*** (two-way analysis of variance (anova)].
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bacterial contamination of samples and tissue viability, prob-
ably accounting for interindividual variation [23]. The pre-
ponderance of female donors in the current study is 
unexplained, but could represent a bias in selection for 
surgical referral or tissue bank consent, factors that could 
not be controlled for. Nonetheless, we did not observe a 
difference between males and females. Individual clinical 
history in tonsil donors may influence response to supe-
rantigens, particularly as the donors were adults with history 
of tonsillitis as the leading indication for surgery. Repeated 
exposure to streptococcal infection might be expected to 
lead to immunity to toxins such as SpeA. As many adults 
have neutralizing antibodies to superantigens [1] and as 
tonsil cells produce abundant immunoglobulin, the detec-
tion of any effect of SpeA within tonsil cell culture is 
therefore all the more remarkable, underlining the signifi-
cance of the effects observed.
SpeA was selected as a paradigm of streptococcal supe-
rantigens as it is strongly associated with the emm 1 geno-
type that has caused disease worldwide, and is historically 
associated with scarlet fever. However, SpeA is less potent 
in human systems than other streptococcal superantigens 
such as SpeJ and SmeZ [8], potentially because SpeA-
responsive TCR-Vβ subsets are smaller, although may 
alter with stimulus strength [24]. We used SpeA at a 
concentration that is physiologically relevant, representing 
typical concentrations achieved in broth culture [11], not-
ing that the concentrations of superantigens within the 
tonsil during infection have not been characterized.
Since the emergence of invasive group A streptococcal 
infections in the late 1980s and description of a supe-
rantigen-associated toxic shock-like syndrome [7], there 
have been a number of reports that describe superantigen-
related effects in invasive human infection [25,26]. Data 
showing superantigen-dependent effects in humanized 
transgenic mice support a role for superantigens in 
severe disease pathogenesis and inflammation [1,9]; 
however, invasive infection is rare, and the evolutionary 
benefit of superantigen production is most likely to be 
manifest in more common non-invasive infections such 
as tonsillo-pharyngitis. Recent studies in humanized 
transgenic mice point to a role for SpeA in permitting 
nasopharyngeal infection through a mechanism that 
requires TCR-Vβ-specific T cell expansion [27], while 
others have highlighted impairment of memory B cell 
responses to first streptococcal skin infections in mice 
[28]. The extent to which the current findings in human 
tonsils explain the reported phenomena in mice is 
unclear, noting that the composition of tonsil is quite 
different to mucosal- and nasal-associated lymphoid tis-
sue. Certainly, if superantigens such as SpeA subvert 
production of antibody and initiation of adaptive immune 
response to S. pyogenes , this provides a rationale for 
inclusion of SpeA and other superantigen toxoids in 
any future S. pyogenes vaccine, in order to provide 
neutralizing immunity against SpeA and other superan-
tigens. A similar approach has been proposed for Staph. 
aureus , where development of natural adaptive immunity 
may be thwarted by exposure to the B cell superantigen 
staphylococcal protein A [29].
Leucocytes from the peripheral blood produce limited 
amounts of immunoglobulin in cell culture; the current 
work underlines the importance of studying relevant 
lymphoid tissue when evaluating responses to bacterial 
pathogens. Indeed, the immunoglobulin released by intact 
tonsil histocultures exceeded levels produced by cell 
suspensions by several orders of magnitude. The unex-
pected findings highlight that even disaggregated tonsil 
cell suspensions may not faithfully reproduce the cellular 
interactions occurring in intact lymphoid follicles. The 
human tonsil provides an excellent model system for 
study of streptococcal disease that can reduce and replace 
the use of animals in such research, although cannot 
completely reproduce the dynamic changes in cell popu-
lations that may occur in a draining lymph node. The 
current work has identified a clear need to further 
understand the impact of superantigens such as SpeA 
on development of adaptive immunity to S. pyogenes , 
elucidation of which is likely to require a nuanced 
approach combining transgenic mouse models and 
human cells.
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Fig. S1. Superantigen-induced tonsil cell TCRVβ profile in 
different tonsil donors. Fold change from baseline profile is 
shown following superantigen stimulation for 7d with SpeA 
(a) and SmeZ (b). Each data point represents a single donor: 
6-8 donors (SpeA), 2-4 donors (SmeZ). In two donors, 
only 4 TCRVβ subsets were checked (Vβ2, 8, 11 and 14). 
Tonsil cell TCRVβ profile for Vβ2, 8, 11 and 14 following 
emm /M1 streptococcal supernatant stimulation in a single 
tonsil donor confirmed SpeA-specific TCRVβ changes (c) 
when comparing supernatants from parent (WT); isogenic 
speA negative (WTΔspeA); and complemented (WTΔspeA 
comp) strains with unstimulated cells (neg) from the same 
tonsil donor. Tonsil cell TCRVβ profile following emm /M89 
supernatant stimulation in a single tonsil donor confirmed 
SmeZ-specific changes (d) when comparing supernatants 
from parent (WT); isogenic smeZ negative (WTΔsmeZ); 
and complemented (WTΔsmeZ comp) strains with un-
stimulated cultures from the same tonsil donor. Results for 
the TCRVβ subsets 1, 2, 4, 7.1, 8, 9, 13.2, 18 and 23 only are 
shown, as there was no alteration from baseline with the 
other TCRVβ subsets tested.
Fig. S2. Effect of soluble factors on tonsil IgG production. 
(a) To determine whether SpeA exposed tonsil cells pro-
duced a secreted factor that could inhibit IgG production, 
cell-free supernatants from SPEA-exposed tonsil cells were 
transferred to naive tonsil cell cultures. IgG production 
by naïve tonsil cells (Negative group, horizontal axis) was 
unaffected by co-incubation with 1% culture supernatant 
transferred from tonsil cells that had been previously ex-
posed to either SpeA 100 ng/ml for 7d (black bars, SPEA 
SN) or medium only (white bars, Negative SN). Fresh tonsil 
cultures did however respond to SpeA (SPEA 100 ng/ml) 
when added directly; IgG after 7d was reduced in all set-
tings. Error bars represent mean + SD. of triplicate IgG lev-
els from one tonsil donor. Data are representative of 2 addi-
tional naïve tonsil cultures, using transferred supernatants 
obtained at different time points. (b) Effect of inhibiting 
cytokines on tonsil IgG production. Tonsil cultures were 
either unstimulated (Negative group, horizontal axis) or 
stimulated with SpeA 100 ng/ml (SPEA 100 ng/ml group, 
horizontal axis) at the start of culture. The following inhib-
itory antibodies (10 μg/ml) were added at days 0, 2 and 5 of 
culture: Negative/normal goat serum, grey bars; goat-anti 
IL4, white bars; goat anti-IL10, black bars; goat anti-TNF; 
spotted bars; goat anti-INF, striped bars. Data show mean 
and SD of 3 experimental replicates. Data representative 
of n = 2 donors for IL4, n = 3 donors for IL10, TNFα and 
INFγ.
